Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
August 2, 2016
IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo
Joanna S Kritikou, Carin I M Dahlberg, Marisa A P Baptista, et al.
The New England Journal of Medicine
|
November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndrome
Kaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
The Journal of Allergy and Clinical Immunology
|
December 27, 2011
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
Joris M van Montfrans, Andy I M Hoepelman, Sigrid Otto, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2025
Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency
Manar Abdalgani, Evelyn R Hernandez, Luis A Pedroza, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2013
Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency
Melissa C Mizesko, Pinaki P Banerjee, Linda Monaco-Shawver, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 18, 2015
PTEN is a negative regulator of NK cell cytolytic function
Edward L Briercheck, Rossana Trotta, Li Chen, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Nature Communications
|
November 20, 2014
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity
Katharina L Willmann, Stefanie Klaver, Figen Doğu, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
August 2, 2016
IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo
Joanna S Kritikou, Carin I M Dahlberg, Marisa A P Baptista, et al.
The New England Journal of Medicine
|
November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndrome
Kaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
The Journal of Allergy and Clinical Immunology
|
December 27, 2011
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
Joris M van Montfrans, Andy I M Hoepelman, Sigrid Otto, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2025
Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency
Manar Abdalgani, Evelyn R Hernandez, Luis A Pedroza, et al.
The Journal of Allergy and Clinical Immunology
|
February 6, 2013
Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency
Melissa C Mizesko, Pinaki P Banerjee, Linda Monaco-Shawver, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 18, 2015
PTEN is a negative regulator of NK cell cytolytic function
Edward L Briercheck, Rossana Trotta, Li Chen, et al.
Frontiers in Immunology
|
March 15, 2021
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny O T Ang, Lucila Kerbauy, et al.
Nature Communications
|
November 20, 2014
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity
Katharina L Willmann, Stefanie Klaver, Figen Doğu, et al.
Science Advances
|
July 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Li Li, Vakul Mohanty, Jinzhuang Dou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 5, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells
Amanda Olson, Ye Li, David Marin, et al.
Page
of 6